Hutchison Medipharma Limited
Pre-Approval PRO BETAStale Activity
No new clinical trials started in 2+ years. Activity may be declining or company may be focusing on existing programs. Last trial started: 9/27/2022
Pipeline by Phase
Therapeutic Focus
Clinical Trials (57)
A Phase III Study of Fruquintinib in Combination With Paclitaxel in Second Line Gastric Cancer(FRUTIGA)
Started: 10/18/2017
Clinical Study on Savolitinib + Osimertinib in Treatment of EGFRm+/MET+ Locally Advanced or Metastatic NSCLC
Started: 9/6/2021
Study on Savolitinib Combined With Osimertinib in Treatment of Advanced NSCLC With MET Amplification
Started: 11/22/2021
A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer
Started: 8/12/2020
Savolitinib for Treating Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Patients
Started: 8/19/2021
Phase III Study of Surufatinib in Treating Advanced Extrapancreatic Neuroendocrine Tumors
Started: 12/7/2015
Phase III Study of Surufatinib in Treating Advanced Pancreatic Neuroendocrine Tumors
Started: 12/7/2015
A Phase III Trial Evaluating Fruquintinib Efficacy and Safety in 3+ Line Colorectal Cancer Patients （FRESCO)
Started: 12/1/2014
HMPL-004 Maintenance Treatment in Subjects With Mild to Moderate Ulcerative Colitis
Started: 6/1/2013
A Phase III Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative Colitis
Started: 3/1/2013
A Phase III Clinical Trial of Fruquintinib in Patients With Advanced Non-small Cell Lung Cancer
Started: 12/9/2015
Savolitinib for Treating Gastric Cancer and Esophagogastric Junction Adenocarcinoma Patients
Started: 7/27/2021
Surufatinib Plus Anti-PD-1/L1 as Maintenance Therapy in Extensive-Stage Small Cell Lung Cancer
Started: 9/27/2022
Clinical Study of HMPL-689 for Relapsed/Refractory Marginal Zone Lymphoma and Follicular Lymphoma
Started: 4/15/2021
Study of Surufatinib Single Agent or Surufatinib Combined With Toripalimab in Patients With Advanced Solid Tumors
Started: 12/26/2019
Phase II Study of HMPL-004 in Patients With Ulcerative Colitis
Started: 2/7/2008
Study of Fruquintinib in Patients With Metastatic Colorectal Cancer
Started: 4/1/2014
A Clinical Trial of Fruquintinib in Patients With Advanced Non-small Cell Lung Cancer
Started: 5/29/2014
Study of Sulfatinib in Treating Advanced Medullary Thyroid Carcinoma and Iodine-refractory Differentiated Thyroid Carcinoma
Started: 2/24/2016
Study of Fruquintinib (HMPL-013) in High Risk Patients With Advanced NSCLC
Started: 5/8/2018
A Phase II Study of Fruquintinib in Combination With Gefitinib in Patients With Advanced Non-small Cell Lung Cancer
Started: 12/1/2016
Study of Surufatinib as Second-line Treatment in Patients With Biliary Tract Carcinoma
Started: 1/3/2017
A Multi-Center, Open-Label Study of Fruquintinib in Solid Tumors and Colorectal, and Breast Cancers
Started: 12/11/2017
A Study of Hutchison MediPharma Limited(HMPL)-523 in Patients With Relapsed or Refractory Mature B-cell Neoplasms
Started: 12/27/2016
The Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Immune Thrombocytopenia Patients
Started: 8/12/2019
A Study of HMPL-689 in Patients With Lymphomas Failed of Standard of Care or no Standard of Care Existed
Started: 8/8/2017
Fruquintinib Food Effect and Proton Pump Inhibitor Study
Started: 9/24/2020
A Study to Assess the Effect of a High Fat Meal on Surufatinib in Healthy Subjects
Started: 8/14/2020
A Study to Assess the Effect of a Strong CYP3A Inhibitor, on Surufatinib in Healthy Subjects
Started: 7/9/2020
Phase I Study of Sulfatinib(HMPL-012) in Patients With Advanced Solid Tumors
Started: 4/1/2010
A Food Effect Phase I Study of the Sulfatinib in Healthy Subjects (HMPL-012)
Started: 12/1/2014
A Phase I Study of Safety and Pharmacokinetics of Volitinib in Combination With Gefitinib in EGFR(+) NSCLC
Started: 4/1/2015
Phase I Study of Fruquintinib(HMPL-013) in Patients With Advanced Solid Tumors
Started: 1/1/2011
A Phase I Study of Epitinib(HMPL-813) in Patients With Advanced Solid Tumors
Started: 10/31/2011
Food Effect Study of Single Dose of Fruquintinib (HMPL-013) in Healthy Subjects
Started: 6/1/2012
A Phase Ib/2 Clinical Study of Fruquintinib Combined With Paclitaxel in the Treatment of Advanced Gastric Cancer
Started: 11/9/2014
Study of Theliatinib (HMPL-309) in Patients With Advanced Solid Tumor
Started: 10/1/2012
A Mass Balance Study to Investigate the Absorption, Metabolism, and Excretion Of [14C] Fruquintinib
Started: 7/1/2016
Phase I Study of HMPL-523+Azacitidine in Elderly Patients With Acute Myeloid Leukemia
Started: 10/9/2018
Phase I Study of the Volitinib (HMPL-504) in Patients With Advanced Solid Tumors
Started: 5/1/2013
A Pharmacokinetic and Bioequivalence Study of Savolitinib Tablets in Healthy Chinese Male Volunteers
Started: 4/16/2019
A Food Effect Phase I Study of the Volitinib in Healthy Subjects
Started: 11/1/2013
Study of Theliatinib (HMPL-309) in Patients With Advanced Solid Tumor
Started: 4/1/2015
A Dose Escalation Study to Assess the Safety and Tolerability of HMPL-453 in Patients With Advanced Solid Malignancies
Started: 1/1/2017
Phase Ib/II Study of Sulfatinib in Treating Advanced Neuroendocrine Tumors
Started: 10/31/2014
To Explore the Pharmacokinetics and Relative Bioavailability of Sulfatinib Capsules in Two Different Manufacturers
Started: 4/2/2018
Phase I Study of the Volitinib (HMPL-504) in Patients With Advanced Solid Tumors
Started: 2/1/2012
A Study of the Safety, Tolerability and Pharmacokinetics of HMPL-523
Started: 5/1/2014
A Study of Safety and Pharmacokinetics of Volitinib With Docetaxel in Patients With Advanced Gastric Cancer
Started: 9/1/2014
A Phase Ib/II Clinical Study Evaluating HMPL-453 Tartrate as Monotherapy and in Combination With Chemotherapy or Toripalimab in Advanced Solid Tumors
Started: 1/22/2022